Literature DB >> 4547952

Open heart surgery in patients with inherited hemoglobinopathies, red cell dyscrasias, and coagulopathies.

M R deLeval, H F Taswell, E J Bowie, G K Danielson.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4547952     DOI: 10.1001/archsurg.1974.01360050016005

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


× No keyword cloud information.
  8 in total

Review 1.  Sickle cell states and the anaesthetist.

Authors:  D W Esseltine; M R Baxter; J C Bevan
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

2.  Cardiac surgery in a patient with multiple myeloma combined with renal amyloidosis.

Authors:  Asako Namai; Masahiro Sakurai; Osamu Sasaki; Kuniaki Meguro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-07-14

3.  Closure of a ventricular septal defect in a patient with von Willebrand disease.

Authors:  S Tatebe; H Kanazawa; Y Yamazaki; E Aoki; Y Sakurai; H Miyamura
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Aorta-coronary bypass in a patient with sickle cell trait.

Authors:  M Heiner; S J Teasdale; T David; A A Scott; M F Glynn
Journal:  Can Anaesth Soc J       Date:  1979-09

5.  Open-heart surgery in sickle-cell haemoglobinopathies: report of 15 cases.

Authors:  D Métras; A O Coulibaly; K Ouattara; A Longechaud; P Millet; J Chauvet
Journal:  Thorax       Date:  1982-07       Impact factor: 9.139

6.  Red cell survival after aortic valve replacement with Björk-Shiley prosthesis in presence of sickle-cell trait.

Authors:  P W Wenham; G L Scott; J D Wisheart
Journal:  Br Heart J       Date:  1978-06

7.  Coronary artery bypass grafting under cardiopulmonary bypass in a patient with beta-thalassemia: report of a case.

Authors:  Tetsuya Horai; Keita Tanaka; Makoto Takeda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Transcatheter Closing Atrial Septal Defect in a Child With Hereditary Spherocytosis.

Authors:  Zhixian Ji; Na Liu; Zhanhui Du; Gang Luo; Zhen Bing; Quansheng Xing; Silin Pan
Journal:  Front Pediatr       Date:  2019-12-17       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.